SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-138756
Filing Date
2020-12-22
Accepted
2020-12-22 20:39:14
Documents
1
Period of Report
2020-12-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 tm2034420d1_form3.html 3  
1 FORM 3 tm2034420d1_form3.xml 3 12297
  Complete submission text file 0001104659-20-138756.txt   13677
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Issuer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address
Werner Milton H. (Reporting) CIK: 0001827621 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39676 | Film No.: 201409525